Redx Pharma in the running for prestigious North of England awards

14 November 2016

We are delighted to announce that Redx Pharma has been acknowledged in two categories at the forthcoming Bionow annual awards.

Now in its 15th year, the Bionow annual awards recognise outstanding enterprise, innovation and endeavour in the biomedical and life science sector in the North.

Redx has been shortlisted in the coveted Bionow Project of the Year Award category, which is sponsored by Waters Corporation.

The work in question is for our innovative development of a reversible Bruton’s Tyrosine Kinase (BTK) Inhibitor, RXC005, a program led by Dr Nicolas Guisot, Research Fellow in Medicinal Chemistry.

RXC005 has the potential to treat leukaemia and other blood cancers in addition to playing a role in other immune system conditions. We are progressing studies to prepare the RXC005 program for first-in-human clinical trials. The aim is to commence these trials in late 2017.

Mark Fahy (London Stock Exchange), Neil Murray (Redx Pharma), Shaun Grady (AZ)

Mark Fahy (London Stock Exchange), Neil Murray (Redx Pharma), Shaun Grady (AZ)

Amy Cooke, Nicolas Guisot, Tilly Bingham (all Redx Pharma)

Amy Cooke, Nicolas Guisot, Tilly Bingham (all Redx Pharma)

Amy Cooke, one of our Drug Metabolism and Pharmacokinetics scientists, is also in the running – shortlisted for the Bionow Promising Technologist of the Year Award, sponsored by Seqiris. This award recognises the achievements of a scientist in the first five years of their biomedical career. We are hoping she can repeat the success of Ralph Kirk, a Senior Medicinal Chemist at Redx, who achieved this accolade in 2013.

Amy, who joined Redx from AstraZeneca in July 2012, has been acknowledged for her outstanding work in DMPK. She has successfully developed a number of key assays critical to Redx Pharma’s drug discovery pipelines, which include some of the most scientifically and commercially promising broad spectrum antibiotics in a generation. She also balanced rapid career progression with the simultaneous attainment of a 1st class honours Chemistry degree from Manchester Metropolitan University.

With outstanding achievement from businesses and individuals recognised across 10 categories, our nominees will join more than 350 members of the North’s life sciences and biomedical community at the Awards dinner on 24th November at the Mere Golf and Spa Resort, Cheshire.